Excitement Around New Oral Treatment and FDA Approval Timeline

This chapter explores a groundbreaking oral medication poised to replace monoclonal antibodies that require injections, highlighting its potential to enhance treatment accessibility. It discusses the excitement surrounding its anticipated FDA approval and the growing preference for oral therapies among patients.